Status:
RECRUITING
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Duke University
Brown University
Conditions:
Suicide
Suicidal
Eligibility:
All Genders
13-24 years
Phase:
PHASE2
Brief Summary
This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or...
Detailed Description
Rationale and Importance of Study: Suicide is currently the second leading cause of death for U.S. youth ages 13-24, responsible for more deaths than any major illness. Youth with serious suicidal be...
Eligibility Criteria
Inclusion
- age 13-24;
- past-week suicidal behavior or ideation with plan or intent
Exclusion
- symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information);
- youth not fluent in English
- parent not fluent in English or Spanish.
Key Trial Info
Start Date :
October 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT05304065
Start Date
October 17 2022
End Date
December 31 2026
Last Update
December 31 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Ronald Reagan Medical Center
Los Angeles, California, United States, 90095-6968
2
Olive View UCLA Education and Research Center
Sylmar, California, United States, 91342
3
Duke University
Durham, North Carolina, United States, 27708
4
Brown University
Providence, Rhode Island, United States, 02912